Previous Article | Next Article 
Molecular and Cellular Biology, February 2001, p. 1001-1010, Vol. 21, No. 4
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.4.1001-1010.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Recruitment of an RNA Polymerase II Complex Is
Mediated by the Constitutive Activation Domain in CREB,
Independently of CREB Phosphorylation
Edward A.
Felinski,
Jeonga
Kim,
Jingfang
Lu, and
Patrick G.
Quinn*
Department of Cellular and Molecular
Physiology, The Pennsylvania State University College of Medicine,
Hershey, Pennsylvania 17033
Received 8 September 2000/Returned for modification 16 October
2000/Accepted 14 November 2000
 |
ABSTRACT |
The cAMP response element binding protein (CREB) is a bifunctional
transcription activator, exerting its effects through a constitutive
activation domain (CAD) and a distinct kinase inducible domain (KID),
which requires phosphorylation of Ser-133 for activity. Both CAD and
phospho-KID have been proposed to recruit polymerase complexes, but
this has not been directly tested. Here, we show that the entire CREB
activation domain or the CAD enhanced recruitment of a complex
containing TFIID, TFIIB, and RNA polymerase II to a linked promoter.
The nuclear extracts used mediated protein kinase A (PKA)-inducible
transcription, but phosphorylation of CRG (both of the CREB activation
domains fused to the Gal4 DNA binding domain) or KID-G4 did not mediate
recruitment of a complex, and mutation of the PKA site in CRG abolished
transcription induction by PKA but had no effect upon recruitment. The
CREB-binding protein (CBP) was not detected in the recruited complex.
Our results support a model for transcription activation in which the
interaction between the CREB CAD and hTAFII130 of TFIID promotes the
recruitment of a polymerase complex to the promoter.
 |
INTRODUCTION |
The cAMP response element (CRE)
mediates both constitutive and cAMP-induced transcription activation of
many genes in a variety of cell types (8, 30, 40, 43, 50,
52). The CRE-binding protein, CREB, a member of the basic
leucine zipper family of transcription factors, binds constitutively to
the CRE in the promoter of the target gene (51) and can
activate constitutive transcription in the absence of hormonal stimuli
(3, 29, 50). Extracellular stimuli that activate protein
kinases can lead to phosphorylation of CREB on Ser-133, e.g., by
cAMP-activated protein kinase A (PKA), resulting in a further
enhancement of transcriptional activation (3, 16, 50).
Mutation of the Ser-133 PKA phosphorylation site in CREB to an alanine
abolishes kinase-inducible activation (17, 50) but not
constitutive activation (3, 29, 50). We and others have
shown that these constitutive and kinase-inducible activities map to
two separate and independently acting transcription activation domains:
a constitutive activation domain (CAD) responsible for activating
constitutive transcription and a kinase-inducible domain (KID) that
mediates activation in response to cAMP-activated PKA (3, 29,
50) and several other kinases (11, 15, 26, 63, 68).
However, the exact mechanism of action of these domains in stimulating constitutive and kinase-inducible transcription has not been defined.
Transcription of a class II gene by RNA polymerase II requires the
assembly of general transcription factors and coactivators around the transcription start site in the gene's promoter (reviewed in references 22 and 44). The general transcription
factors (TFIID, TFIIA, TFIIB, TFIIF-pol II, TFIIE, and TFIIH) were
initially identified as the basic nuclear components required to
reconstitute in vitro transcription by RNA polymerase II (9,
54-56, 66, 67). These general factors are required for accurate
and optimal positioning of RNA polymerase II at the transcriptional
start site, melting the template and facilitating promoter clearance to
allow synthesis of an mRNA transcript (reviewed in references 21, 44 and 72). Much work has focused on the role of
activators in mediating recruitment of these essential factors, which
is a necessary first step in transcription initiation. In particular, many activators interact with TFIID (5, 12-14, 23, 28, 38, 47,
61, 62, 65) or with TFIIB (7, 25, 36, 57). Recent
work has demonstrated that the general factors, RNA polymerase II, and
coactivators often exist as macromolecular complexes in cells rather
than as isolated factors (18, 22). Thus, transcription activators must recruit and modify the activity of complexes for promoter recognition (TFIID) (1, 48, 49) and mRNA
synthesis (Pol II holoenzyme) (32, 33, 39), processes
which are often facilitated by coactivators (2, 19, 27, 34, 59,
70, 71).
Although recruitment of a holoenzyme complex is essential to
transcription in vivo, the polymerase still must be positioned properly
at the start site in the promoter of the target gene to accurately
initiate the synthesis of a transcript. Recruitment of the TFIID
complex represents a crucial first target in assembly of a functional
polymerase complex. Early studies of in vitro transcription showed that
binding of TFIID to a promoter enhanced the association of other
polymerase complex components, which did not readily exchange with
other promoters in template challenge assays (66). This
suggested a processive mechanism for assembly of a functional
polymerase complex. Even though it is now recognized that general
factors are found in complexes rather than as isolated factors, the
same type of mechanism may operate in vivo, where TFIID and holoenzyme
exist as distinct complexes in cells. Support for this idea comes from
experiments in which VP16 mutants that cannot bind to TFIID are
defective for holoenzyme recruitment (31). In addition,
several lines of evidence have suggested that CREB plays a role in
recruitment of TFIID and RNA polymerase II, as discussed below.
Early evidence for the recruitment activity of CREB came from the
demonstration that inclusion of activating transcription factor
(ATF)/CRE sites upstream of the adenovirus major late promoter resulted
in extension of the footprint downstream of the TATA region to include
the transcription initiation site (20). Although the
ATF/CREB family member responsible for this activity was not determined
in those studies, it was found that the complex responsible for the
expanded footprint included RNA polymerase II and TFIIB (24). Those studies were done without phosphorylation of
ATF/CREB proteins. Subsequent studies provided evidence that the CAD in CREB binds TFIID through its TATA binding protein-associated factors (TAFs) (69) and that this interaction occurs through
hTAF130 or dTAF110 in TFIID (12, 13, 64) and is mediated
by a conserved set of hydrophobic residues in the CREB CAD
(12). Phosphorylation of the KID in CREB promotes binding
of the CREB-binding protein (CBP) (34, 53), which has also
been shown to bind TFIIB and RNA helicase A associated with holoenzyme
(34, 41, 42). Thus, both of the CREB activation domains,
the CAD and the KID, have been proposed to mediate recruitment of the
polymerase complex (Fig. 1) (12,
34, 41).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Models for transcription activation by the two
activation domains of CREB. (A) A sequential model for CAD activation
involves interaction between CAD and the hTAF130 subunit of TFIID to
recruit TFIID to the promoter, thereby increasing the rate of formation
of the polymerase complex and the overall rate of transcription
(12, 13). (B) An alternative model involves bivalent
recruitment of TFIID by CAD and holoenzyme by P-KID interaction with
CBP and RNA helicase A (41, 42).
|
|
We have suggested that the mechanism of activation of the CREB CAD
involves recruitment of TFIID through interaction with hTAFII130,
followed by association of the polymerase complex through its
interaction with promoter-bound TFIID (Fig. 1A; 12).
Similar mechanisms have been proposed based on the interactions between other transcription activators and TAF components of TFIID (14, 37, 38, 61, 65). On the other hand, Nakajima and coworkers showed that phospho-CREB bound to purified holoenzyme preparations in
vitro and that the CAD (Q2) domain bound to TFIID (42).
Based on these results, a mechanism for CREB activation was proposed in
which each domain, CAD and P-KID, recruited individual components of
the transcription machinery, TFIID and holoenzyme, independently (Fig.
1B). However, the CAD can activate transcription on its own (3,
29, 50), which suggests that the CAD is able to reach the end
point of polymerase recruitment through its recruitment of TFIID.
Neither of these hypotheses has been directly tested by measuring
recruitment of RNA polymerase II to a template.
To further address the question of polymerase complex recruitment by
the CREB activation domains, we designed an assay to determine the
contributions of the constitutive and kinase-inducible activation
domains in CREB to recruitment of an RNA polymerase II-containing
complex to promoter DNA. We adapted an agarose electrophoretic mobility
shift assay (Ag-EMSA) (35), previously used to show recruitment of purified TATA-binding protein (TBP) by the factor Zta,
to detect the formation of polymerase complexes on promoter DNA. A
template containing five Gal4 sites upstream of a minimal promoter was
incubated with purified proteins containing either or both of the CREB
activation domains fused to the Gal4 DNA binding domain (CRGs) and rat
liver nuclear extract (RLNE) to determine which CRGs could promote
complex formation on the promoter. These binding reactions were done
under conditions where CRG stimulated in vitro transcription, which was
enhanced by phosphorylation of Ser- 133 in CREB with PKA. In addition,
a sensitive procedure was developed to determine whether specific
components, such as TBP or RNA polymerase II, are present in the
recruited complex. We also tested whether phosphorylation of CRG
contributes to this recruitment process, by testing a PKA
phosphorylation site mutant of CRG and by phosphorylation of CRG or KID
by preincubation with protein kinase A. Our results show that the CAD
in CREB mediates recruitment of a complex containing TBP, RNA
polymerase II, and TFIIB and that this process is unaffected by protein
kinase A-mediated phosphorylation of the CREB activation domain.
 |
MATERIALS AND METHODS |
Expression and purification of CRG proteins.
Coding regions
for the various CRG proteins (CRG, G4-DBD, CAD-G4, KID-G4, and
CRG-S133A) were subcloned into the pBacPak baculovirus expression
vector, and Sf9 insect cells in culture were infected using the
BaculoGold baculovirus system (Pharmingen). The CRG proteins are
identical to those described previously except that they contain amino
acids (aa) 4 to 94 rather than aa 4 to 147 of the Gal4 DNA binding
domain (50). All constructs include CREB aa 1 to 8 to
provide appropriate translation initiation signals. In addition,
the constructs include the following amino acids of the CREB protein:
CRG, aa 1 to 276; CAD-G4, aa 165 to 252; and KID-G4, aa 98 to 142. CRG
proteins were purified from Sf9 nuclear extracts using DNA affinity
chromatography. Oligonucleotides containing five Gal4 binding sites and
cohesive ends for HindIII were ligated for an average
length of a 10-mer and then ligated to a biotinylated linker. The
resulting biotinylated DNA template was bound to streptavidin-coated
Dynabeads (Dynal) in Tris-EDTA (TE), pH 7.5, plus 1 M KCl at room
temperature overnight. Beads were immobilized with a magnet and washed
once with an equal volume of TE and 1 M KCl and then twice with DAP-A
(20 mM HEPES, pH 7.9, 1 mM EDTA, 15% glycerol, 0.05% NP-40, 1 mM
dithiothreitol [DTT], 0.5 mM phenylmethylsulfonyl fluoride [PMSF])
plus 100 mM KCl. The affinity support was then incubated with the Sf9
nuclear extracts (0.5 mg of protein/1 pmol of bound DNA) in DAP-A plus
70 mM (NH4)2SO4 at room temperature
for 15 min. Bound proteins were washed three times in an equal volume
of DAP-A and 100 mM KCl and then eluted from the affinity support with
0.2 volumes of DAP-A plus 1 M KCl at room temperature for 15 min.
Protein was tested for purity on a silver-stained gel and stored at
80°C.
Production of RLNE.
Livers from four 125- to 150-g freshly
killed rats were homogenized in 80 ml of homogenization buffer (10 mM
HEPES, pH 7.9, 25 mM KCl, 0.5 mM spermidine, 0.15 mM spermine, 1 mM
EDTA, 2 M sucrose, 10% glycerol, 0.5 mg of leupeptin/ml, 1 mg of
pepstatin/ml, 1 mM benzamidine, 0.5 mM PMSF) at 4°C, filtered, and
centrifuged through a homogenization buffer gradient at 24,000 rpm in
an SW27 rotor for 30 min at 4°C to pellet nuclei. Nuclei were lysed
in a nuclear lysis buffer (10 mM HEPES, pH 7.9, 100 mM KCl, 3 mM MgCl2, 0.1 mM EDTA, 10% glycerol, 1 mM DTT, 0.5 mg of
leupeptin/ml, 1 mg of pepstatin/ml, 1 mM benzamidine, 0.5 mM PMSF) with
a Dounce homogenizer, and chromatin was precipitated from the lysate by the addition of a 4 M (NH4)2SO4
solution, pH 7.9, to a 400 mM final concentration. Precipitated
chromatin was removed by centrifugation at 35,000 rpm in a Ti60 rotor
at 4°C for 1 h. Nuclear proteins were precipitated with the
addition of solid (NH4)2SO4 to 0.3 g/ml followed by centrifugation at 35,000 rpm in a Ti60 rotor for 25 min at 4°C. Pelleted proteins were resuspended in dialysis buffer (25 mM HEPES, pH 7.9, 40 mM KCl, 0.1 mM EDTA, 1 mM DTT, 10% glycerol) and
were dialyzed against the same buffer four times for 30 min each time
at 4°C. Protein extracts were concentrated by centrifugation through
a Millipore concentrating filter in a tabletop centrifuge at 3,200 rpm
for 5 to 6 h at 4°C. Nuclear extracts were stored in small
aliquots at
80°C.
In vitro transcription assay.
In vitro transcription was
performed as previously described (51), with the following
modifications. In vitro reactions contained 50 µg of nuclear extract,
150 fmol of 5XGT-Luc template (750 fmol of Gal4 sites), and 750 fmol of
CREB-Gal4 protein. The mRNA synthesized was quantitated by primer
extension analysis. Where indicated, 0.5 U of PKA plus 0.5 uM okadaic
acid were added to phosphorylate P-KID-G4 and P-CRG, after which 0.5 U
of PKI was added to inhibit further PKA activity. Equivalent results were obtained for using two different preparations of purified proteins
and nuclear extracts.
Ag-EMSA.
Probe DNA (150 bp) with five Gal4 binding sites
(5×GT) and a minimal TATA-containing promoter (see Fig. 4A) was end
labeled with [
-32P]dATP using Klenow. Five femtomoles
of probe was incubated with 10 fmol of purified protein and 3 µg of
RLNE (see above) in 1× Ag-EMSA binding buffer (12.5 mM HEPES, pH 7.9, 12.5% glycerol, 5 mM MgCl2, 70 mM KCl, 0.2 mM EDTA, 10 mM
2-mercaptoethanol, 0.5 mg of bovine serum albumin/ml, 40 µg of
poly-dI/dC/ml) for 15 min on a nutator at 4°C. Reactions were run on
a 1% Seakem agarose gel (FMC) in 1× buffer G (45 mM Tris, pH 8.3, 45 mM boric acid, 0.5 mM EDTA, 5 mM MgAc) at 100 V for 2 h. The gel
was then placed on filter paper, dried overnight at room temperature
under vacuum, and exposed to film to detect complexes. For antibody
supershifting experiments, 1 µl of primary antibody was incubated
with 3 µg of RLNE in 1× Ag-EMSA binding buffer for 1 h on a
nutator at 4°C. Ten femtomoles of purified protein, 2 µl of
biotinylated secondary antibody, and 3 µl of streptavidin-coated
Dynabeads were added, and the samples were incubated for an additional
1 h on a nutator at 4°C. Five femtomoles of probe was then
added, and the samples were incubated for an additional 15 min at
4°C. Reactions were run on a 1% Seakem agarose gel, and complexes
were visualized as described above.
 |
RESULTS |
CRG recruits a large complex to the promoter DNA in an
Ag-EMSA.
To obtain functional CRG proteins containing either or
both of the functional CREB activation domains (Fig.
2A) for our assays, we expressed
recombinant baculovirus in Sf9 insect cells and purified the
expressed CRGs, using DNA affinity chromatography. The eluted CRG
proteins were separated on a sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel and silver
stained (Fig. 2B), which shows that the CRG proteins were purified to
near homogeneity. The recombinant CRG proteins and RLNEs used in our
binding studies were also tested for their ability to support
constitutive and PKA-induced transcription controlled by a minimal
promoter with five Gal4 binding sites (5×GT), which was also used for
the binding studies (see Fig. 4A). As illustrated in Fig. 2C, CRG
increased transcription above the background level obtained with the
Gal4 DNA binding domain (G4-DBD) alone, and this transcription was enhanced significantly by phosphorylation of CRG with PKA. In addition,
the CRG-S133A PKA phosphorylation site mutant provided stimulation of
constitutive but not PKA-inducible activity, indicating that the
constitutive and PKA-inducible CRG activities previously described in
transfected cells (50) are reproduced in the in vitro
transcription system.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 2.
Purification of CRG proteins and their function in an in
vitro transcription assay. (A) The schematic shows the domains of
the CRG (CREB-Gal4) proteins used, including the amino acids of
CREB included in each. (B) CRG proteins were expressed in Sf9 insect
cells using a baculovirus system. Proteins were purified from
nuclear extracts using DNA affinity chromatography. Purified
protein was separated on an SDS-15% PAGE gel and was
silver stained by standard methods to visualize the protein bands. (C)
Purified G4-DBD and CRG proteins were tested for activation in an
in vitro transcription system with and without PKA added to the
reaction as indicated.
|
|
The concentrations of purified CRG proteins shown in Fig. 2B were
determined empirically by testing their binding to a DNA probe encoding
a Gal4 binding site in a classic EMSA. The results from these
experiments (Fig. 3) showed that the
purified proteins retain DNA binding activity, and the correlation
between amount of protein added and amount of probe bound was used to
estimate protein concentrations.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Mobility shift analysis of purified CRG proteins with a
Gal4 probe. Affinity purified G4-CAD, G4-KID and CRG were diluted 1:20,
1:50, and 1:100 and bound to 10 fmol of 32P-labeled Gal4
probe in a standard EMSA. Bound and free probes were separated on a 5%
polyacrylamide mobility shift gel. Densitometry was used to quantify
the relative amounts of probe bound by the various protein samples. A
representative experiment is shown.
|
|
To test for stimulation of complex formation on promoter DNA by CRG, we
adapted an Ag-EMSA that had been previously used to separate free
promoter from Zta/TBP/TFIIA-bound promoter (35). Agarose
gels are used because their larger matrix makes it possible to resolve
much larger complexes, such as those formed by RNA polymerase II
(megadaltons), than those that can be resolved (kilodaltons) on the
polyacrylamide gels normally used for gel shift assays. In our method
(see Materials and Methods), a 32P-end-labeled DNA probe
(Fig. 4A), which contains five Gal4
binding sites ligated to a TATA-containing minimal promoter (5×GT),
was incubated with purified CRG proteins and RLNE to provide the
general transcription factors under conditions identical to those used for in vitro transcription. Bound and free probes were separated on a
1% Seakem agarose gel (Fig. 4B). The binding of G4-DBD or CRG alone
produced only a slight decrease in the mobility of the probe in these
gels (Fig. 4B, lanes 2 to 4 and 5 to 7).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 4.
CRG stimulates the formation of a large complex at the
promoter in an Ag-EMSA. (A) The Ag-EMSA method uses a
32P-end-labeled, 150-bp DNA probe that contains five Gal4
binding sites (5×G) and a TATA-containing minimal promoter. The probe
is incubated with purified protein and RLNE under conditions that allow
DNA binding (see Materials and Methods). (B) Ag-EMSA binding reactions
included 5 fmol of probe incubated with 1, 5, or 10 fmol of purified
G4-DBD or CRG protein and 3 µg of RLNE where indicated. Complexes
were resolved and visualized as indicated in Materials and Methods.
|
|
In the presence of RLNE, the addition of increasing amounts of CRG
protein to the binding reactions produced an increase in the formation
of a large, slowly migrating complex on the DNA probe (Fig. 4B, lanes
13 to 15). No such effect was observed with similar amounts of DBD
protein (Fig. 4B, lanes 10 to 12), and complex formation was dependent
on the presence of RLNE in the reaction (in Fig. 4B, compare lanes 5 to
7 with lanes 13 to 15). These results indicate that CRG bound at the
promoter was specifically stimulating the recruitment of a large
complex of proteins from the extract to the promoter DNA.
The complex recruited to the promoter by CRG contains TFIID, TFIIB,
and RNA polymerase II.
To determine whether the complex
recruited by CRG has components expected to be found in an RNA
polymerase II complex, we developed a supershift assay to test the
complexes for the presence of specific components, such as RNA
polymerase II. The method, illustrated in Fig.
5A, makes use of a
multiorder binding array to cross-link the recruited complexes and
derives component specificity from the use of primary antibodies
specific for CREB or for proteins known to be required in the RNA
polymerase II complex, including TFIIB, TBP of TFIID, and the large
subunit of pol II. Because the complexes formed in this assay are
extremely large (in the megadalton range), the addition of a
specific primary antibody (kDa) alone is not sufficient to produce a
detectable increase in the size of the complex (mDa) (Fig. 5B, lane 5),
even in the presence of secondary antibody (anti-CREB; Fig. 5B, lane
6). It was necessary to include a biotinylated secondary antibody
specific for the primary antibody along with streptavidin-coated
Dynabeads (Fig. 5B, lane 9) to cross-link the complexes into larger
"supercomplexes" that could then be detected through their shift to
a higher molecular weight on the agarose gel. Supershifting was not
observed when any of the components (primary antibody, secondary
antibody, streptavidin beads) were omitted from the reaction (Fig. 5B,
lanes 6 to 8). The addition of a primary antibody specific for CREB,
together with the other supershifting reagents, resulted in a visible
shift of the complex to a higher molecular weight on the gel (Fig. 5C, lane 4 versus lane 6). Likewise, antibodies specific for TFIIB or the
large subunit of RNA polymerase II (Pol) produced a comparable shift in
the molecular weight of the complex (Fig. 5C, lanes 7 and 8). Antibody
against the TBP subunit of TFIID also retarded the complex, but to a
somewhat lesser extent (Fig. 5C, lane 9), which may be attributable to
reduced accessibility of TBP within the TFIID complex or interference
of the antibody with further growth of the complex. Antibodies specific
for an irrelevant T7 epitope did not supershift the complex (Fig. 5C,
lane 10).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 5.
The complex recruited to the promoter by CRG contains
components of an RNA polymerase II complex, as indicated by an antibody
supershift assay. (A) The method uses rabbit primary antibodies
specific for components of the polymerase complex, a biotinylated goat
anti-rabbit secondary antibody, and streptavidin-conjugated Dynabeads
to bind the complexes into larger "supercomplexes." (B) Binding
reactions contained primary antibody (1° Ab) directed against CREB,
secondary antibody (2° Ab), and/or beads, as indicated, with 5 fmol
of probe, 10 fmol of purified CRG, and 3 µg of RLNE. (C) Primary
antibodies specific for CREB, TFIIB, the large subunit of RNA
polymerase II, TBP, or an irrelevant T7 antibody were included with
secondary antibody and streptavidin beads where indicated, as in panel
B.
|
|
CAD, but not KID, is sufficient to recruit the complex to the
promoter DNA.
To test whether stimulation of complex
formation was occurring specifically through one or both of
the two activation domains of CREB, purified KID-G4 or
CAD-G4 proteins (Fig. 2B) were included in Ag-EMSA binding reactions.
The CAD was able to stimulate significant complex formation on the
promoter DNA (Fig. 6, lane 8), while the
level observed with KID-G4 was no different from that with G4-DBD alone
(Fig. 6, lane 9 versus lane 7). This indicates that the CAD, but not
the KID, of CREB is sufficient to recruit the complex to the promoter
DNA. However, the KID would not be expected to mediate recruitment in
the absence of phosphorylation by PKA, because CBP has been shown to
bind specifically to the KID in CREB only when the KID is
phosphorylated (6, 34, 53).

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 6.
The CAD but not the KID of CREB is sufficient to recruit
a complex to the promoter. Ag-EMSA binding reactions included 5 fmol of
probe DNA, 10 fmol of purified G4-DBD, KID-G4, CAD-G4, or CRG, and 3 µg of RLNE where indicated.
|
|
Recruitment of the complex to the promoter by CRG is independent of
CRG phosphorylation by PKA.
To determine whether phosphorylation
of CRG by PKA had an effect on recruitment of a complex to the promoter
DNA, we tested P-CRG and P-KID-G4. To avoid artifacts due to
phosphorylation of nuclear extract proteins by PKA, we incubated
CREB-Gal4 proteins with PKA and terminated the reaction with an
inhibitor of the kinase before the addition of phosphorylated factors
to the binding reaction. Phosphorylation of KID-G4 and CRG by PKA and
the maintenance of the phosphorylation state under the conditions of
the Ag-EMSA was confirmed by Western blot using an antibody specific
for CREB that is phosphorylated on the Ser-133 PKA
phosphorylation site (Fig. 7A). The
extent of phosphorylation was assessed by including [
-32P]ATP of known specific activity in an in
vitro kinase assay. Under the conditions used in these
experiments, CRG and KID-G4 were phosphorylated stoichiometrically by
PKA. However, phosphorylation of CRG by PKA had no effect on the amount
of complex formed on the promoter DNA (Fig. 7B, lane 7 versus lane 8).
Likewise, phosphorylation of KID-G4 did not allow it to stimulate
complex formation (Fig. 7B, lane 6). This is in contrast to the ability
of PKA to stimulate CRG-mediated transcription with the same reagents
in the in vitro transcription assay (Fig. 2C). To determine whether
inadvertent phosphorylation of CRG by endogenous PKA in the extracts
was having an unrecognized effect on complex recruitment by CRG, we
tested CRG-S133A, a PKA phosphorylation site mutant, in the Ag-EMSA. Complex recruitment by CRG-S133A was indistinguishable from recruitment by wild-type CRG (Fig. 7B, lane 9 versus lane 7) and was also equivalent in the presence of PKA (Fig. 7B, lane 9 versus lane 10). The
result with CRG S133A provides further evidence that PKA
phosphorylation is not playing a role in recruitment of the complex to
the promoter DNA by CRG. These results indicate that recruitment by CRG
is independent of PKA phosphorylation and provide direct evidence that
phosphorylation of the KID does not allow it to recruit the polymerase
complex in this system, whether the KID acts alone or in concert with
the CAD in CRG.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 7.
Recruitment of the complex by CRG is independent of CRG
phosphorylation by PKA. (A) To test for phosphorylation of CRG and
KID-G4 by PKA in the Ag-EMSA system, we incubated 100 fmol of each
protein without and with 5 U of PKA under the same conditions used in
the Ag-EMSA binding reactions. Samples were separated on an SDS-15%
PAGE gel and transferred to a membrane, and a Western blot was
performed with a primary antibody specific for Ser-133 phosphorylated
CREB. (B) Ten femtomoles of each purified protein was included with 5 fmol of probe and 3 µg of RLNE in Ag-EMSA binding reactions as
indicated. Five units of PKA were included where shown.
|
|
CBP antibody does not supershift the complex recruited by CRG.
Because interaction with CBP has been proposed to mediate activation of
transcription by phosphorylated CREB, we were interested to see if an
antibody specific for CBP could supershift the complex recruited to the
promoter by CRG. Endogenous CBP was detected with the CBP antibody in
the RLNE (Fig. 8A), demonstrating that it
is present in significant amounts in the recruitment assay. We are also
able to immunoprecipitate CBP from nuclear extracts with this antibody,
indicating that it recognizes native CBP (data not shown). Using this
same CBP antibody, we tested PKA-phosphorylated CRG to see if inclusion
of CBP in the recruited complex was dependent on phosphorylation of
CRG. Phosphorylation of CRG still did not allow supershifting of the
complex by the CBP primary antibody (Fig. 8B, lane 10), indicating
either that CBP is not present in the complex recruited to the promoter
by CRG, regardless of the CRG phosphorylation state, or that the amino
terminal CBP epitope is masked in the complex. In addition, two other
antibodies directed against amino and carboxy terminal epitopes in CBP
were tested alone and together, but they also failed to produce a
supershift (data not shown). The maintenance of phosphorylation of CRG
under the conditions of the assay was again confirmed by Western blot, as described above (Fig. 7A).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 8.
Phosphorylated CRG does not recruit CBP to the complex.
(A) To confirm the presence of CBP in the RLNE, a Western blot was
performed using an antibody specific for CBP. RLNE (250 µg) was
separated on an SDS-5% PAGE gel and transferred to a membrane, and a
Western blot was performed. A 70-kDa N-terminal CBP fragment was
synthesized in a coupled in vitro transcription-translation reaction
and included on the gel as a positive control for the antibody. (B) A
supershift assay was performed similar to that shown in Fig. 5C, except
5 U of PKA was included to phosphorylate the CRG protein. The indicated
primary antibodies were included along with biotinylated secondary
antibody and streptavidin beads. The CBP antibody was the same as that
described in the Fig. 7A legend.
|
|
 |
DISCUSSION |
Based on previous results showing an interaction between the CREB
CAD and the dTAF110 or hTAF130 subunit of TFIID (12, 13, 60,
69), we proposed a model for CAD activation through sequential recruitment of the TFIID and polymerase complexes. We developed the
Ag-EMSA method reported here to test this hypothesis directly. The
results of our Ag-EMSA experiments demonstrate the following: (i) CRG
is able to recruit a polymerase complex to the promoter; (ii) this
complex contains TFIID, TFIIB, and RNA polymerase II; (iii) the CAD,
but not the KID, of CREB is sufficient to mediate recruitment; (iv)
recruitment is independent of the phosphorylation state of CRG; and (v)
CBP was not detected in the recruited complex, even when CRG was phosphorylated.
CRG stimulation of the formation of a polymerase complex required the
CREB activation domain, as no increase in complex formation was
detected with G4-DBD and RLNE. The incubation of G4-DBD or CRG with the
probe DNA showed only a very minor shift in the mobility of the probe
in the agarose gel (Fig. 4B, lanes 2 to 7), corresponding to the
binding of the purified proteins to the Gal4 sites, as shown in Fig. 4.
The addition of increasing amounts of CRG to RLNE produced a
corresponding increase in the amount of complex with very slow mobility
in the gel. This indicates that a factor binding to the DNA probe is
specifically stimulated by the presence of CRG and is not simply a
function of Gal4 protein binding to the probe, consistent with a role
of the CREB activation domains in active recruitment of such a complex.
It is apparent in some experiments that incubation of RLNE with a
promoter DNA probe in an Ag-EMSA binding reaction produced a modest
level of complex formation on the promoter DNA in the absence of
activator. This effect is particularly evident in Fig. 6 and 7. This
minor complex formation likely represents the low level of polymerase
complex formation and in vitro transcription that can occur in the
absence of an activator (4). The formation of this complex
was consistent and was unchanged by the addition of purified G4-DBD to
the binding reaction (Fig. 6), suggesting that it did indeed reflect
spontaneous, activator-independent binding.
That the complex recruited to the promoter by CRG contains factors
expected to be found in an RNA polymerase II complex was demonstrated
by our antibody supershifting experiments (Fig. 5). Through the use of
a multiorder binding array, we were able to detect further shifts in
the molecular weights of the large complexes formed on the DNA, which
were specific for the CREB activation domain and for the general
transcription factors known to be required in the polymerase complex.
The multicomponent supershifting method utilized in these studies
retains the specificity provided by the primary antibody, as in the
single component supershifting used in a classic polyacrylamide gel
shift assay. The method we report here is far more sensitive than
previously described procedures utilizing Western blotting (36,
58). Based on our results with CRG, we can readily detect a
supershift with ~5% of the protein needed for detection with an avid
antibody by Western blot. An advantage of using a combination of a
selective Gal4-targeted activation domain together with heterogeneous
nuclear extracts that support transcription activation is that it is
possible to test for the inclusion of specific factors recruited to the
complex. As expected, supershifting of the complex was observed with a CREB primary antibody, due to the presence of CRG bound to the probe.
Comparable supershifting was also seen with primary antibodies specific
for the general transcription factor TFIIB or the large subunit of RNA
polymerase II. Antibody against the TBP subunit of TFIID produced a
smaller supershift, which may indicate that the antibody produced a
steric block to full complex formation or that access to TBP was
limited. It has been shown that a complex containing TFIID, TFIIB, and
RNA polymerase II-TFIIF is sufficient to transcribe a supercoiled
template (46). Thus, the presence of TFIIB, RNA polymerase
II, and TBP in the complex recruited to the promoter by CRG (Fig. 5C),
together with the ability of CRG to stimulate transcription under
identical conditions (Fig. 2C), suggests that the recruited complex is functional.
The recruitment activity of CRG is mediated through the CAD in CREB, as
evidenced by the recruitment of the complex by purified CAD-G4 but not
by KID-G4 (Fig. 6). Although the full-length activation domain of CRG
was more effective than CAD-G4 in promoting recruitment, this is not
due to phosphorylation of KID, because CRG-S133A is as effective as CRG
in recruitment. This result is consistent with previous studies
demonstrating that the CAD interacts with the general transcription
machinery through the dTAF110 or hTAF130 subunit of TFIID (12,
13, 60, 69). Mammalian cells contain a homologue of dTAF110,
hTAF130, in which the domains that interact with TAF250 in TFIID and
with the CREB or Sp1 activation domains are highly conserved (60,
64). A yeast screen for TAF110 interaction-defective CAD mutants
mapped the CREB amino acids required for interaction with TAF110 to a
central hydrophobic cluster of amino acids in the CAD
(12). As will be demonstrated elsewhere, the interaction between the CAD and TAF is necessary and sufficient for constitutive transcription (Felinski and Quinn, unpublished data). Mutations in
these hydrophobic residues which abolished interaction in the yeast
two-hybrid system also abolished the following: (i) direct interaction
between the CAD and the TAF, (ii) recruitment of the RNA polymerase II
complex in the assay described here, and (iii) transcription activation
by these mutated CAD-G4 proteins in vivo. This establishes a genetic
link between CAD-TAF interaction, recruitment, and transcription. Taken
together, our results provide strong support for the idea that the
mechanism by which the CAD activates transcription involves binding and
recruitment of TFIID by the CREB CAD, which in turn facilitates
recruitment of the polymerase complex (Fig. 1A).
To determine whether the KID had potential recruiting activity that was
simply masked by the strong activity of the CAD, we tested the KID
alone. Even when phosphorylated, KID-G4 had no effect on recruitment in
this assay. In addition, recruitment of the polymerase complex by CRG
was not affected by phosphorylation of CRG by PKA or by a mutation,
CRG-S133A, in KID that prevents phosphorylation by PKA. Identical
results were obtained when we employed a functional assay (single-round
transcription) to assess recruitment; neither KID alone nor PKA
phosphorylation of the entire CREB activation domain had any effect
upon recruitment (29). Thus, results from two independent
assays, which measured distinct end points, involving direct assessment
of recruitment or the presence of a functional polymerase complex
(29), indicate that KID alone is incapable of recruiting a
polymerase complex, even when phosphorylated. An important difference
between the experiments reported here and those of Nakajima et al.
(41) showing that CBP mediated interaction between
phosphorylated CREB and holoenzyme is that we included template in the
recruitment reaction, whereas Nakajima et al. supplied template and
other factors subsequent to the interaction assay. Thus, a strict
interpretation of that result is that CBP can mediate interaction
between CREB and holoenzyme. However, phosphorylated CREB would have to
interact with holoenzyme in order to affect any step in transcription
initiation, so the demonstration of such an interaction does not
indicate that recruitment is the step affected. When recruitment was
assayed independently here, we saw no effect of phosphorylation of CRG on this process.
The coactivator CBP has been demonstrated to interact with CREB when it
is phosphorylated on Ser-133 (6, 34). Thus, the fact that
we were unable to detect the presence of CBP in the complex, even when
CRG was phosphorylated, was somewhat of a surprise. CBP has been
suggested to mediate recruitment of the polymerase complex by
simultaneously interacting with phosphorylated CREB and RNA helicase A
of the holoenzyme complex to enhance activation by CREB (41, 42,
45). The observation that CBP was not detected in the complex,
even in the presence of PKA (Fig. 8B), suggests either that
phosphorylation of CRG is not sufficient to recruit CBP under these
conditions, that CBP is present in the complex but that the CBP
epitopes required for antibody recognition are masked by interaction
with another factor, or that CBP association is not stable to
electrophoresis. We did confirm by Western blot that CBP is present in
significant quantity in our RLNE and thus is available in the Ag-EMSA
binding reactions (Fig. 8A). Regardless of whether CBP is absent or
masked, the observation that PKA does not influence recruitment by CRG
under conditions where it stimulates transcription in a phosphorylation
site-dependent manner indicates that recruitment of CBP or of the
polymerase complex in general may not be required for phosphorylated
CREB to augment induction of transcription. Immunodepletion of CBP from
nuclear extracts had no effect upon induction by PKA (data not shown),
but we were unable to deplete CBP by more than ~75%, even when using
large quantities of a combination of amino- and carboxy-directed
antibodies. We cannot exclude the possibility that the residual CBP,
which is inaccessible to antibodies recognizing amino- and
carboxy-terminal epitopes, may be in a functional complex required for
transcription activation by phosphorylated CREB.
In summary, the results presented here demonstrate that recruitment of
a complex containing TBP, TFIIB, and polymerase II can be facilitated
by the presence of CRG bound to an upstream enhancer. This recruitment
activity is solely a function of the CAD in CREB and was unaffected by
phosphorylation of KID-G4, whether acting as a distinct domain or in
concert with the CAD in CRG. The data presented here show that CAD-G4
effectively recruits an RNA polymerase II complex to the promoter but
do not support a role for P-CREB-CBP in recruitment of a polymerase
complex. Work reported elsewhere showed that CAD-G4 but not KID-G4
mediated single-round transcription, a functional measure of
recruitment, whereas phosphorylation of CRG stimulated later steps in
the reaction: isomerization, as estimated by abortive initiation, and
promoter clearance and/or reinitiation, as estimated by multiple-round transcription (29). Taken together, our results are
consistent with the idea that the CREB CAD can interact with the TAF130
subunit of TFIID, leading to recruitment of a polymerase complex and
the establishment of constitutive transcription (Fig. 1A). The
experiments reported here are in excellent agreement with experiments
recently reported in which artificial recruitment of TFIID to a
promoter could establish transcription in mammalian cells, whereas
recruitment of holoenzyme could not (10). Finally, the
assay described here should be useful, at least in principle, in the
identification of specific factors recruited to a variety of
protein-nucleic acid complexes under different conditions.
 |
ACKNOWLEDGMENTS |
This work was supported by a grant from the National Institutes
of Health, R01DK43871.
The authors thank Dongying Cui for unpublished results with anti-CBP
antibodies and David Spector and Anita Hopper for critical reading of
the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Cellular and Molecular Physiology, H166, The Pennsylvania State
University College of Medicine, 500 University Dr., Hershey, PA 17033. Phone: (717) 531-6182. Fax: (717) 531-7667. E-mail:
pquinn{at}psu.edu.
 |
REFERENCES |
| 1.
|
Albright, S. R., and R. Tjian.
2000.
TAFs revisited: more data reveal new twists and confirm old ideas.
Gene
242:1-13[CrossRef][Medline].
|
| 2.
|
Arias, J.,
A. S. Alberts,
P. Brindle,
F. X. Claret,
T. Smeal,
M. Karin,
J. Feramisco, and M. Montminy.
1994.
Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.
Nature
370:226-229[CrossRef][Medline].
|
| 3.
|
Brindle, P.,
S. Linke, and M. Montminy.
1993.
Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors.
Nature
364:821-824[CrossRef][Medline].
|
| 4.
|
Buratowski, S.,
S. Hahn,
L. Guarente, and P. A. Sharp.
1989.
Five intermediate complexes in transcription initiation by RNA polymerase II.
Cell
56:549-561[CrossRef][Medline].
|
| 5.
|
Burley, S. K., and R. G. Roeder.
1996.
Biochemistry and structural biology of transcription factor IID (TFIID).
Annu. Rev. Biochem.
65:769-799[CrossRef][Medline].
|
| 6.
|
Chrivia, J.,
R. Kwok,
N. Lamb,
M. Hagiwara,
M. Montminy, and R. Goodman.
1993.
Phosphorylated CREB binds specifically to the nuclear protein CBP.
Nature
365:855-859[CrossRef][Medline].
|
| 7.
|
Colgan, J.,
H. Ashali, and J. L. Manley.
1995.
A direct interaction between a glutamine-rich activator and the N terminus of TFIIB can mediate transcriptional activation in vivo.
Mol. Cell. Biol.
15:2311-2320[Abstract].
|
| 8.
|
Delegeane, A. M.,
L. H. Ferland, and P. L. Mellon.
1987.
Tissue-specific enhancer of the human glycoprotein hormone -subunit gene: dependence on cyclic AMP-inducible elements.
Mol. Cell. Biol.
7:3994-4002[Abstract/Free Full Text].
|
| 9.
|
Dignam, J. D.,
P. L. Martin,
B. S. Shastry, and R. G. Roeder.
1983.
Eukaryotic gene transcription with purified components.
Methods Enzymol.
104:582-598.
|
| 10.
|
Dorris, D. R., and K. Struhl.
2000.
Artificial recruitment of TFIID, but not RNA polymerase II holoenzyme, activates transcription in mammalian cells.
Mol. Cell. Biol.
20:4350-4358[Abstract/Free Full Text].
|
| 11.
|
Du, K., and M. Montminy.
1998.
CREB is a regulatory target for the protein kinase Akt/PKB.
J. Biol. Chem.
273:32377-32379[Abstract/Free Full Text].
|
| 12.
|
Felinski, E. A., and P. G. Quinn.
1999.
The CREB constitutive activation domain interacts with TATA-binding protein-associated factor 110 (TAF110) through specific hydrophobic residues in one of the three subdomains required for both activation and TAF110 binding.
J. Biol. Chem.
274:11672-11678[Abstract/Free Full Text].
|
| 13.
|
Ferreri, K.,
G. Gill, and M. Montminy.
1994.
The cAMP-regulated transcription factor CREB interacts with a component of the TFIID complex.
Proc. Natl. Acad. Sci. USA
91:1210-1213[Abstract/Free Full Text].
|
| 14.
|
Gill, G.,
E. Pascal,
Z. H. Tseng, and R. Tjian.
1994.
A glutamine-rich hydrophobic patch in transcription factor SP1 contacts the dTAFII 110 component of the drosophila TFIID complex and mediates transcriptional activation.
Proc. Natl. Acad. Sci. USA
91:192-196[Abstract/Free Full Text].
|
| 15.
|
Ginty, D. D.,
A. Bonni, and E. Greenberg.
1994.
Nerve growth factor activates a ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB.
Cell
77:713-725[CrossRef][Medline].
|
| 16.
|
Gonzalez, G. A., and M. R. Montminy.
1989.
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.
Cell
59:675-680[CrossRef][Medline].
|
| 17.
|
Gonzalez, G. A.,
K. K. Yamamoto,
W. H. Fischer,
D. Karr,
P. Menzel,
W. I. Biggs,
W. W. Vale, and M. R. Montminy.
1989.
A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence.
Nature
337:749-752[CrossRef][Medline].
|
| 18.
|
Greenblatt, J.
1997.
RNA polymerase II holoenzyme and transcriptional regulation.
Curr. Opin. Cell Biol.
9:310-319[CrossRef][Medline].
|
| 19.
|
Guermah, M.,
S. Malik, and R. G. Roeder.
1998.
Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Spl.
Mol. Cell. Biol.
18:3234-3244[Abstract/Free Full Text].
|
| 20.
|
Hai, T. W.,
M. Horikoshi,
R. G. Roeder, and M. R. Green.
1988.
Analysis of the role of the transcription factor ATF in the assembly of a functional preinitiation complex.
Cell
54:1043-1051[CrossRef][Medline].
|
| 21.
|
Hampsey, M.
1998.
Molecular genetics of the RNA polymerase II general transcriptional machinery.
Microbiol. Mol. Biol. Rev.
62:465-503[Abstract/Free Full Text].
|
| 22.
|
Hampsey, M., and D. Reinberg.
1999.
RNA polymerase II as a control panel for multiple coactivator complexes.
Curr. Opin. Genet. Dev.
9:132-139[CrossRef][Medline].
|
| 23.
|
Hoey, T.,
R. O. J. Weinzierl,
G. Gill,
J. L. Chen,
B. D. Dynlacht, and R. Tjian.
1993.
Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators.
Cell
72:247-260[CrossRef][Medline].
|
| 24.
|
Horikoshi, M.,
T. Hai,
Y. S. Lin,
M. R. Green, and R. G. Roeder.
1988.
Transcription factor ATF interacts with the TATA factor to facilitate establishment of a preinitiation complex.
Cell
54:1033-1042[CrossRef][Medline].
|
| 25.
|
Ing, N. H.,
S. Y. Beekman,
S. Y. Tsai,
M. J. Tsai, and B. W. O'Malley.
1992.
Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).
J. Biol. Chem.
267:17617-17623[Abstract/Free Full Text].
|
| 26.
|
Iordanov, M.,
K. Bender,
T. Ade,
W. Schmid,
C. Sachsenmaier,
K. Engel,
M. Gaestel,
H. J. Rahmsdorf, and P. Herrlich.
1997.
CREB is activated by UVC through a p38/HOG-1-dependent protein kinase.
EMBO J.
16:1009-1022[CrossRef][Medline].
|
| 27.
|
Ito, M.,
C. X. Yuan,
S. Malik,
W. Gu,
J. D. Fondell,
S. Yamamura,
Z. Y. Fu,
X. Zhang,
J. Qin, and R. G. Roeder.
1999.
Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.
Mol. Cell
3:361-370[CrossRef][Medline].
|
| 28.
|
Jacq, X.,
C. Brou,
Y. Lutz,
I. Davidson,
P. Chambon, and L. Tora.
1994.
Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor.
Cell
79:107-117[CrossRef][Medline].
|
| 29.
|
Kim, J.,
J.-F. Lu, and P. Quinn.
2000.
Distinct cAMP response element binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.
Proc. Natl. Acad. Sci. USA
97:11292-11296[Abstract/Free Full Text].
|
| 30.
|
Kim, K. S.,
M. K. Lee,
J. Carroll, and T. H. Joh.
1993.
Both the basal and inducible transcription of the tyrosine hydroxylase gene are dependent upon a cAMP response element.
J. Biol. Chem.
268:15689-15695[Abstract/Free Full Text].
|
| 31.
|
Kobayashi, N.,
P. J. Horn,
S. M. Sullivan,
S. J. Triezenberg,
T. G. Boyer, and A. J. Berk.
1998.
DA-complex assembly activity required for VP16C transcription activity.
Mol. Cell. Biol.
18:4023-4031[Abstract/Free Full Text].
|
| 32.
|
Koleske, A. J., and R. A. Young.
1995.
The RNA polymerase II holoenzyme and its implications for gene regulation.
Trends Biochem. Sci.
20:113-116[CrossRef][Medline].
|
| 33.
|
Koleske, A. J., and R. A. Young.
1994.
An RNA polymerase II holoenzyme responsive to activators.
Nature
368:466-469[CrossRef][Medline].
|
| 34.
|
Kwok, R. P. S.,
J. R. Lundblad,
J. C. Chrivia,
J. P. Richards,
H. P. Bachinger,
R. G. Brennan,
S. G. E. Roberts,
M. R. Green, and R. H. Goodman.
1994.
Nuclear protein CBP is a coactivator for the transcription factor CREB.
Nature
370:223-226[CrossRef][Medline].
|
| 35.
|
Lieberman, P., and A. Berk.
1991.
The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction.
Genes Dev.
5:2441-2454[Abstract/Free Full Text].
|
| 36.
|
Lin, Y. S., and M. R. Green.
1991.
Mechanism of action of an acidic transcriptional activator in vitro.
Cell
64:971-981[CrossRef][Medline].
|
| 37.
|
May, M.,
G. Mengus,
L. Carre,
P. Chambon, and I. Davidson.
1997.
Human TAFII28 promotes transcriptional stimulation by the activation function 2 of the retinoid X receptors.
EMBO J.
15:3093-3104[Medline].
|
| 38.
|
Mengus, G.,
M. May,
L. Carre,
P. Chambon, and I. Davidson.
1997.
Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells.
Genes Dev.
11:1381-1395[Abstract/Free Full Text].
|
| 39.
|
Meyer, V. E., and R. A. Young.
1998.
RNA polymerase II holoenzymes and subcomplexes.
J. Biol. Chem.
273:27757-27760[Free Full Text].
|
| 40.
|
Montminy, M. R., and L. M. Bilezikjian.
1987.
Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.
Nature
328:175-178[CrossRef][Medline].
|
| 41.
|
Nakajima, T.,
C. Uchida,
S. F. Anderson,
C. G. Lee,
J. Hurwitz,
J. D. Parvin, and M. Montminy.
1997.
RNA helicase A mediates association of CBP with RNA polymerase II.
Cell
90:1107-1112[CrossRef][Medline].
|
| 42.
|
Nakajima, T.,
C. Uchida,
S. F. Anderson,
J. D. Parvin, and M. Montminy.
1997.
Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors.
Genes Dev.
11:738-747[Abstract/Free Full Text].
|
| 43.
|
Nilson, J. H.,
J. A. Bokar,
B. Andersen,
R. Bohinski,
G. Kennedy,
R. A. Keri,
T. A. Farmerie, and R. A. Fenstermaker.
1989.
CRE-binding proteins interact cooperatively to enhance placental-specific expression of the glycoprotein hormone alpha-subunit gene.
Ann. N. Y. Acad. Sci.
564:77-85[Abstract].
|
| 44.
|
Orphanides, G.,
T. Lagrange, and D. Reinberg.
1996.
The general transcription factors of RNA polymerase II.
Genes Dev.
10:2657-2683[Free Full Text].
|
| 45.
|
Parker, D.,
K. Ferreri,
T. Nakajima,
V. J. LaMorte,
R. Evans,
S. C. Koerber,
C. Hoeger, and M. R. Montminy.
1996.
Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism.
Mol. Cell. Biol.
16:694-703[Abstract].
|
| 46.
|
Parvin, J., and P. Sharp.
1993.
DNA topology and a minimal set of basal factors for transcription by RNA polymerase II.
Cell
73:533-540[CrossRef][Medline].
|
| 47.
|
Petty, K. J.,
Y. I. Krimkevich, and D. Thomas.
1996.
A TATA binding protein-associated factor functions as a coactivator for thyroid hormone receptors.
Mol. Endocrinol.
10:1632-1645[Abstract].
|
| 48.
|
Pugh, B. F., and R. Tjian.
1992.
Diverse transcriptional functions of the multisubunit eukaryotic TFIID complex.
J. Biol. Chem.
267:679-682[Free Full Text].
|
| 49.
|
Pugh, B. F., and R. Tjian.
1991.
Transcription from a TATA-less promoter requires a multisubunit TFIID complex.
Genes Dev.
5:1935-1945[Abstract/Free Full Text].
|
| 50.
|
Quinn, P. G.
1993.
Distinct activation domains within cAMP response element-binding protein (CREB) mediate basal and cAMP-stimulated transcription.
J. Biol. Chem.
268:16999-17009[Abstract/Free Full Text].
|
| 51.
|
Quinn, P. G., and D. K. Granner.
1990.
Cyclic AMP-dependent protein kinase regulates transcription of the phosphoenolpyruvate carboxykinase gene but not binding of nuclear factors to the cyclic AMP regulatory element.
Mol. Cell. Biol.
10:3357-3364[Abstract/Free Full Text].
|
| 52.
|
Quinn, P. G.,
T. W. Wong,
M. A. Magnuson,
J. B. Shabb, and D. K. Granner.
1988.
Identification of basal and cyclic AMP regulatory elements in the promoter of the phosphoenolpyruvate carboxykinase gene.
Mol. Cell. Biol.
8:3467-3475[Abstract/Free Full Text].
|
| 53.
|
Radhakrishnan, I.,
G. C. Perez-Alvarado,
D. Parker,
H. J. Dyson,
M. R. Montminy, and P. E. Wright.
1997.
Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions.
Cell
91:741-752[CrossRef][Medline].
|
| 54.
|
Reinberg, D.,
M. Horikoshi, and R. G. Roeder.
1987.
Factors involved in specific transcription in mammalian RNA polymerase II. Functional analysis of initiation factors IIA and IID and identification of a new factor operating at sequences downstream of the initiation site.
J. Biol. Chem.
262:3322-3330[Abstract/Free Full Text].
|
| 55.
|
Reinberg, D., and R. G. Roeder.
1987.
Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE.
J. Biol. Chem.
262:3310-3321[Abstract/Free Full Text].
|
| 56.
|
Reinberg, D., and R. G. Roeder.
1987.
Factors involved in specific transcription by mammalian RNA polymerase II. Transcription factor IIS stimulates elongation of RNA chains.
J. Biol. Chem.
262:3331-3337[Abstract/Free Full Text].
|
| 57.
|
Roberts, S. G.,
I. Ha,
E. Maldonado,
D. Reinberg, and M. R. Green.
1993.
Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation.
Nature
363:741-744[CrossRef][Medline].
|
| 58.
|
Roberts, S. G. E.,
B. Choy,
S. S. Walker,
Y.-S. Lin, and M. R. Green.
1995.
A role for activator-mediated TFIIB recruitment in diverse aspects of transcriptional regulation.
Curr. Biol.
5:508-516[CrossRef][Medline].
|
| 59.
|
Ryu, S.,
S. Zhou,
A. G. Ladurner, and R. Tjian.
1999.
The transcriptional cofactor CRSP is required for activity of the enhancer-binding protein Sp1.
Nature
397:446-450[CrossRef][Medline].
|
| 60.
|
Saluja, D.,
M. Vassallo, and N. Tanese.
1998.
Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators.
Mol. Cell. Biol.
18:5734-5743[Abstract/Free Full Text].
|
| 61.
|
Sauer, F.,
S. K. Hansen, and R. Tjian.
1995.
Multiple TAFIIs directing synergistic activation of transcription.
Science
270:1783-1788[Abstract/Free Full Text].
|
| 62.
|
Sauer, F.,
D. Wassarman,
G. Rubin, and R. Tjian.
1996.
TAFII's mediate activation of transcription in the Drosophila embryo.
Cell
87:1271-1284[CrossRef][Medline].
|
| 63.
|
Sun, P.,
H. Enslen,
P. S. Myung, and R. A. Maurer.
1994.
Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity.
Genes Dev.
8:2527-2539[Abstract/Free Full Text].
|
| 64.
|
Tanese, N.,
D. Saluja,
M. F. Vassallo,
J. L. Chen, and A. Admon.
1996.
Molecular cloning and analysis of two subunits of the human TFIID complex: hTAFII130 and hTAFII100.
Proc. Natl. Acad. Sci. USA
93:13611-13616[Abstract/Free Full Text].
|
| 65.
|
Thut, C. J.,
J. Chen,
R. Klemm, and R. Tjian.
1995.
p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.
Science
267:100-103[Abstract/Free Full Text].
|
| 66.
|
Van Dyke, M. W.,
M. Sawadogo, and R. G. Roeder.
1989.
Stability of transcription complexes on class II genes.
Mol. Cell. Biol.
9:342-344[Abstract/Free Full Text].
|
| 67.
|
Weil, P. A.,
D. S. Luse,
J. Segall, and R. G. Roeder.
1979.
Selective and accurate transcription of the Ad2 major late promoter in a soluble system dependent on purified RNA polymerase II and DNA.
Cell
18:469-484[CrossRef][Medline].
|
| 68.
|
Xie, H., and T. L. Rothstein.
1995.
Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in B lymphocytes stimulated through surface Ig.
J. Immunol.
154:1717-1723[Abstract].
|
| 69.
|
Xing, L.,
V. K. Gopal, and P. G. Quinn.
1995.
cAMP response element-binding protein (CREB) interacts with transcription factors IIB and IID.
J. Biol. Chem.
270:17488-17493[Abstract/Free Full Text].
|
| 70.
|
Yang, C.,
L. H. Shapiro,
M. Rivera,
A. Kumar, and P. K. Brindle.
1998.
A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions.
Mol. Cell. Biol.
18:2218-2229[Abstract/Free Full Text].
|
| 71.
|
Yang, W., and L. P. Freedman.
1999.
20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor.
J. Biol. Chem.
274:16838-16845[Abstract/Free Full Text].
|
| 72.
|
Zawel, L., and D. Reinberg.
1995.
Common themes in assembly and function of eukaryotic transcription complexes.
Annu. Rev. Biochem.
64:533-561[CrossRef][Medline].
|
Molecular and Cellular Biology, February 2001, p. 1001-1010, Vol. 21, No. 4
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.4.1001-1010.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cauvi, D. M., Cauvi, G., Pollard, K. M.
(2006). Constitutive Expression of Murine Decay-Accelerating Factor 1 Is Controlled by the Transcription Factor Sp1. J. Immunol.
177: 3837-3847
[Abstract]
[Full Text]
-
Green, M. R., Yoon, H., Boss, J. M.
(2006). Epigenetic Regulation during B Cell Differentiation Controls CIITA Promoter Accessibility. J. Immunol.
177: 3865-3873
[Abstract]
[Full Text]
-
Huang, X., Zhang, J., Lu, L., Yin, L., Xu, M., Wang, Y., Zhou, Z., Sha, J.
(2004). Cloning and expression of a novel CREB mRNA splice variant in human testis. Reproduction
128: 775-782
[Abstract]
[Full Text]
-
Nie, M., Pang, L., Inoue, H., Knox, A. J
(2003). Transcriptional Regulation of Cyclooxygenase 2 by Bradykinin and Interleukin-1{beta} in Human Airway Smooth Muscle Cells: Involvement of Different Promoter Elements, Transcription Factors, and Histone H4 Acetylation. Mol. Cell. Biol.
23: 9233-9244
[Abstract]
[Full Text]
-
Boulon, S., Dantonel, J.-C., Binet, V., Vie, A., Blanchard, J.-M., Hipskind, R. A., Philips, A.
(2002). Oct-1 Potentiates CREB-Driven Cyclin D1 Promoter Activation via a Phospho-CREB- and CREB Binding Protein-Independent Mechanism. Mol. Cell. Biol.
22: 7769-7779
[Abstract]
[Full Text]
-
Doi, J., Takemori, H., Lin, X.-z., Horike, N., Katoh, Y., Okamoto, M.
(2002). Salt-inducible Kinase Represses cAMP-dependent Protein Kinase-mediated Activation of Human Cholesterol Side Chain Cleavage Cytochrome P450 Promoter through the CREB Basic Leucine Zipper Domain. J. Biol. Chem.
277: 15629-15637
[Abstract]
[Full Text]
-
Asahara, H., Santoso, B., Guzman, E., Du, K., Cole, P. A., Davidson, I., Montminy, M.
(2001). Chromatin-Dependent Cooperativity between Constitutive and Inducible Activation Domains in CREB. Mol. Cell. Biol.
21: 7892-7900
[Abstract]
[Full Text]
-
Belmonte, N., Phillips, B. W., Massiera, F., Villageois, P., Wdziekonski, B., Saint-Marc, P., Nichols, J., Aubert, J., Saeki, K., Yuo, A., Narumiya, S., Ailhaud, G., Dani, C.
(2001). Activation of Extracellular Signal-Regulated Kinases and CREB/ATF-1 Mediate the Expression of CCAAT/Enhancer Binding Proteins {beta} and -{delta} in Preadipocytes. Mol. Endocrinol.
15: 2037-2049
[Abstract]
[Full Text]
-
Felinski, E. A., Quinn, P. G.
(2001). The coactivator dTAFII110/hTAFII135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB. Proc. Natl. Acad. Sci. USA
10.1073/pnas.241337698v1
[Abstract]
[Full Text]
-
Streeper, R. S., Hornbuckle, L. A., Svitek, C. A., Goldman, J. K., Oeser, J. K., O'Brien, R. M.
(2001). Protein Kinase A Phosphorylates Hepatocyte Nuclear Factor-6 and Stimulates Glucose-6-phosphatase Catalytic Subunit Gene Transcription. J. Biol. Chem.
276: 19111-19118
[Abstract]